Per Pfeiffer

机构：University of Southern Denmark, Odense University Hospital · ORCID：0000-0002-2925-0586

发表论文 547 篇 · 总被引 22636 次 · h-index 61

代表论文

• Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study (2024 · Journal of Clinical Oncology · 被引 92)
• Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study (2025 · British Journal of Cancer · 被引 36)
• Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX (2025 · JAMA Oncology · 被引 19)
• Single-cycle neoadjuvant pembrolizumab in patients with stage I-III MMR-deficient colon cancer: Final analysis of the RESET-C study. (2025 · Journal of Clinical Oncology · 被引 16)
• Neoadjuvant Pembrolizumab in Stages I–III Deficient Mismatch Repair Colon Cancer (2024 · Annals of Surgery · 被引 14)
• Efficacy and Safety of the Anti-IL1RAP Antibody Nadunolimab (CAN04) in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Advanced/Metastatic Pancreatic Cancer (2024 · Clinical Cancer Research · 被引 14)